Paper Details
- Home
- Paper Details
Comparison of the Inhibitory Effects of Clotrimazole and Ketoconazole against Human Carboxylesterase 2.
Author: ChenJing, DouTongyi, GeGuangbo, LiuKexin, MengQiang, SunHuijun, WangChangyuan, WangDalong, WuJingjing, ZhaoShan, ZhaoTingting
Original Abstract of the Article :
BACKGROUND: Both clotrimazole and ketoconazole have been verified to have an inhibitory effect on CYP3A4. hCE2 is an enzyme closely related to the side effects of several anti-cancer drugs. However, the interactions between hCE2, clotrimazole, and ketoconazole remain unclear. OBJECTIVE: The objecti...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.2174/1389200222666210210115509
データ提供:米国国立医学図書館(NLM)
Clotrimazole and Ketoconazole: A Comparative Study of Their Inhibitory Effects on Human Carboxylesterase 2
In the vast desert of drug interactions, understanding the effects of different medications on enzyme activity is crucial for patient safety. This research examines the inhibitory effects of clotrimazole and ketoconazole, two antifungal agents, on human carboxylesterase 2 (hCE2), an enzyme closely associated with the side effects of several anti-cancer drugs. The authors compare the inhibitory properties of these two antifungal agents, revealing significant differences in their effects on hCE2 activity.Clotrimazole: A Potential Agent for Reducing hCE2-Mediated Side Effects
This research, much like a skilled desert navigator, explores the intricacies of drug-enzyme interactions, uncovering the potential of clotrimazole to modulate hCE2 activity. The findings suggest that clotrimazole, compared to ketoconazole, exhibits a stronger inhibitory effect on hCE2, potentially reducing the side effects associated with certain anti-cancer drugs. These findings pave the way for further research into the potential of clotrimazole as a co-administered agent to enhance the efficacy and safety of anti-cancer therapies.Optimizing Cancer Treatment Strategies
This research, like a shimmering oasis in the desert of drug development, offers valuable insights into optimizing cancer treatment strategies. By understanding the inhibitory effects of various medications on enzymes like hCE2, we can develop more effective and safer therapeutic approaches for cancer patients. This research is a testament to the ongoing quest for better and safer treatments for those battling cancer.Dr.Camel's Conclusion
This research, much like a camel caravan carrying precious knowledge, reveals the potential of clotrimazole to reduce the side effects associated with certain anti-cancer drugs by inhibiting hCE2 activity. These findings offer a glimmer of hope in the ongoing quest for improved cancer treatments.Date :
- Date Completed 2021-12-28
- Date Revised 2021-12-28
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.